New nonopioid approach disrupts protein interaction to reduce neuropathic pain

Researchers at Boston Children's Hospital have discovered a novel mechanism to reduce neuropathic pain by disrupting the interaction between sodium channel Na V 1.8 and the scaffolding protein ankyrin-G, leading to the development of nonopioid therapeutics by Mimetic Medicines.

Why it matters. This breakthrough could lead to long-acting, nonopioid treatments for chronic neuropathic pain, potentially improving patient outcomes and reducing side effects.